South Korea would seek to invest 1 trillion won (US$853.8 million) annually in developing home-grown materials and equipment used to produce microchips, a senior lawmaker said yesterday, after Japan tightened curbs on exports of some high-tech materials to the nation.
Japan on Monday said that it would tighten regulations on exports of materials used in smartphone displays and chips to South Korea amid a widening dispute over South Koreans who were forced to work for Japanese firms during World War II.
“We are doing a preliminary feasibility analysis [on the investment],” South Korean Legislator Cho Jeong-sik from the Democratic Party told reporters after meeting with officials from the presidential office and government ministries to discuss a response to Japan’s decision.
The export curbs could hamper production of South Korea’s chip giants Samsung Electronics Co and SK Hynix Inc, as the two chemicals targeted are essential, analysts said.
Data firm IHS Markit said that the Japanese trade restrictions would add to global trade tensions.
Asian exporters are already being strained by a prolonged slowdown in the global electronics sectors.
“A reduction or elimination in the availability of these materials will significantly impede the production of memory and other semiconductor chips, impacting major semiconductor manufacturers, including Samsung Electronics and SK Hynix,” IHS Markit executive director of semiconductor research Len Jelinek said in a note.
The Japanese Ministry of Economy, Trade and Industry on Tuesday said that its decision to tighten controls was not a contravention of the WTO, rebuffing South Korea’s earlier claims.
Cho shrugged off criticism in local media that the government is not laying out countermeasures swiftly, but he did not provide further details on the nature of the spending.
Shares in South Korean chip materials makers jumped after the government’s spending plan was made public.
Shares of Ram Technology Inc and Ocean Bridge Co Ltd, local firms producing chemicals used in chip manufacturing process, rose as much as 20 percent and 15 percent respectively.
JPMorgan Chase & Co chief executive officer Jamie Dimon on Tuesday quipped that his company is likely to outlast the Chinese Communist Party (CCP), while reiterating the bank’s commitment to the country in wide-ranging comments that also touched on Taiwan, free speech and former US president Donald Trump. “We hope to be there [in China] for a long time,” Dimon told a panel discussion at the Boston College Chief Executives Club. Relaying a “joke” he made during a recent visit to Hong Kong, he said “The communist party is celebrating its 100th year. So is JPMorgan. And I’ll make you a
The Kaohsiung City Government yesterday said it would impose a property hoarding tax as it is seeking to contain speculation in the real-estate market, calling recent price increases “abnormal.” The announcement came in support of the Ministry of Finance’s call for local governments to levy a high tax rate on people with more than one property. Ministry officials on Tuesday discussed strategies to rein in speculation with the nation’s six special municipalities, as well as the Hsinchu city and county governments. About 84,000 out of 1.06 million housing units in Kaohsiung are not residential property, the city government said in a
BOOST EXPECTED: Higher market prices would offset effects of the industry’s transition to more climate-friendly production methods, a company official said China Steel Corp (CSC, 中鋼) expects steel demand to increase on the back of governments around the world subsidizing infrastructure construction amid a stabilizing COVID-19 pandemic, CSC chairman Wong Chao-tung (翁朝棟) told an investors’ meeting yesterday. “After getting through the hard times, I foresee at least one year, very possibly two years, of strong steel market,” Wong said. Calling a dip in steel prices a “short respite for the market,” Wong said that it would likely bounce back early next year on the back of mild winter temperatures around the world allowing construction activity. Despite COVID-19 spikes in some regions and increased
PharmaEssentia Corp (藥華醫藥) shares have jumped 80.56 percent since the company obtained a US polycythemia vera (PV) drug license for its new interferon drug Besremi (ropeginterferon alfa-2b-njft) on Nov. 12. Shares on Friday closed at NT$195 in Taipei trading, up from the stock’s closing price of NT$108 on Nov. 12. PV is a rare, chronic and life-threatening blood cancer linked to a stem cell mutation in the bone marrow that results in an overproduction of blood cells and places sufferers at risk of having a blood clot, stroke or heart attack. PharmaEssentia is preparing to make Besremi available in the US in the